Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular albumin

Janet C. Ludwig, Carol L. Hoppens, Linda M Mcmanus, Glen E. Mott, R. N Pinckard

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Human neutrophilic polymorphonuclear leukocytes (PMN) stimulated with N′-formyl-methionyl-leucyl-phenylalanine (FMLP) in the presence of cytochalasin B but in the absence of human serum albumin (HSA) synthesized only small amounts of platelet-activating factor (PAF) that attained maximum levels within 60-120 s after stimulation; in addition, no release of PAF occurred. However, in the presence of 2.5 mg HSA/ml, there was a threefold increase in PAF synthesis, 30-40% of which was released within 5 min after FMLP stimulation. In the presence of 50 mg HSA/ml there was at least a fourfold increase in PAF synthesis and release, with maximal synthesis occurring 10-20 min after stimulation. Thus, the presence of HSA during PMN stimulation not only induced an albumin dose-dependent increase in PAF release but significantly augmented the synthesis of PAF. In contrast to PAF synthesis and release, the presence or absence of HSA had no effect upon lysosomal enzyme secretion from FMLP-stimulated PMN, which was maximal within 30-60 s after stimulation. These results demonstrate that HSA plays an essential role in vitro in the synthesis and release of PAF from human PMN, and support the hypothesis that there is a cyclic PAF synthesis-release coupling mechanism in the stimulated human PMN.

Original languageEnglish (US)
Pages (from-to)337-347
Number of pages11
JournalArchives of Biochemistry and Biophysics
Volume241
Issue number2
DOIs
StatePublished - 1985

Fingerprint

Platelet Activating Factor
Albumins
Neutrophils
Modulation
Serum Albumin
N-Formylmethionine Leucyl-Phenylalanine
Cytochalasin B
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN) : Role of extracellular albumin. / Ludwig, Janet C.; Hoppens, Carol L.; Mcmanus, Linda M; Mott, Glen E.; Pinckard, R. N.

In: Archives of Biochemistry and Biophysics, Vol. 241, No. 2, 1985, p. 337-347.

Research output: Contribution to journalArticle

@article{7cb42437d6a84fa89a2590e92ec2ccc9,
title = "Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular albumin",
abstract = "Human neutrophilic polymorphonuclear leukocytes (PMN) stimulated with N′-formyl-methionyl-leucyl-phenylalanine (FMLP) in the presence of cytochalasin B but in the absence of human serum albumin (HSA) synthesized only small amounts of platelet-activating factor (PAF) that attained maximum levels within 60-120 s after stimulation; in addition, no release of PAF occurred. However, in the presence of 2.5 mg HSA/ml, there was a threefold increase in PAF synthesis, 30-40{\%} of which was released within 5 min after FMLP stimulation. In the presence of 50 mg HSA/ml there was at least a fourfold increase in PAF synthesis and release, with maximal synthesis occurring 10-20 min after stimulation. Thus, the presence of HSA during PMN stimulation not only induced an albumin dose-dependent increase in PAF release but significantly augmented the synthesis of PAF. In contrast to PAF synthesis and release, the presence or absence of HSA had no effect upon lysosomal enzyme secretion from FMLP-stimulated PMN, which was maximal within 30-60 s after stimulation. These results demonstrate that HSA plays an essential role in vitro in the synthesis and release of PAF from human PMN, and support the hypothesis that there is a cyclic PAF synthesis-release coupling mechanism in the stimulated human PMN.",
author = "Ludwig, {Janet C.} and Hoppens, {Carol L.} and Mcmanus, {Linda M} and Mott, {Glen E.} and Pinckard, {R. N}",
year = "1985",
doi = "10.1016/0003-9861(85)90555-7",
language = "English (US)",
volume = "241",
pages = "337--347",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN)

T2 - Role of extracellular albumin

AU - Ludwig, Janet C.

AU - Hoppens, Carol L.

AU - Mcmanus, Linda M

AU - Mott, Glen E.

AU - Pinckard, R. N

PY - 1985

Y1 - 1985

N2 - Human neutrophilic polymorphonuclear leukocytes (PMN) stimulated with N′-formyl-methionyl-leucyl-phenylalanine (FMLP) in the presence of cytochalasin B but in the absence of human serum albumin (HSA) synthesized only small amounts of platelet-activating factor (PAF) that attained maximum levels within 60-120 s after stimulation; in addition, no release of PAF occurred. However, in the presence of 2.5 mg HSA/ml, there was a threefold increase in PAF synthesis, 30-40% of which was released within 5 min after FMLP stimulation. In the presence of 50 mg HSA/ml there was at least a fourfold increase in PAF synthesis and release, with maximal synthesis occurring 10-20 min after stimulation. Thus, the presence of HSA during PMN stimulation not only induced an albumin dose-dependent increase in PAF release but significantly augmented the synthesis of PAF. In contrast to PAF synthesis and release, the presence or absence of HSA had no effect upon lysosomal enzyme secretion from FMLP-stimulated PMN, which was maximal within 30-60 s after stimulation. These results demonstrate that HSA plays an essential role in vitro in the synthesis and release of PAF from human PMN, and support the hypothesis that there is a cyclic PAF synthesis-release coupling mechanism in the stimulated human PMN.

AB - Human neutrophilic polymorphonuclear leukocytes (PMN) stimulated with N′-formyl-methionyl-leucyl-phenylalanine (FMLP) in the presence of cytochalasin B but in the absence of human serum albumin (HSA) synthesized only small amounts of platelet-activating factor (PAF) that attained maximum levels within 60-120 s after stimulation; in addition, no release of PAF occurred. However, in the presence of 2.5 mg HSA/ml, there was a threefold increase in PAF synthesis, 30-40% of which was released within 5 min after FMLP stimulation. In the presence of 50 mg HSA/ml there was at least a fourfold increase in PAF synthesis and release, with maximal synthesis occurring 10-20 min after stimulation. Thus, the presence of HSA during PMN stimulation not only induced an albumin dose-dependent increase in PAF release but significantly augmented the synthesis of PAF. In contrast to PAF synthesis and release, the presence or absence of HSA had no effect upon lysosomal enzyme secretion from FMLP-stimulated PMN, which was maximal within 30-60 s after stimulation. These results demonstrate that HSA plays an essential role in vitro in the synthesis and release of PAF from human PMN, and support the hypothesis that there is a cyclic PAF synthesis-release coupling mechanism in the stimulated human PMN.

UR - http://www.scopus.com/inward/record.url?scp=0021886160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021886160&partnerID=8YFLogxK

U2 - 10.1016/0003-9861(85)90555-7

DO - 10.1016/0003-9861(85)90555-7

M3 - Article

C2 - 4037794

AN - SCOPUS:0021886160

VL - 241

SP - 337

EP - 347

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -